| |
| |
|
| Insider
Information: |
Ho Carole |
| Relationship: |
Chief Medical Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
143,605 |
|
|
Indirect Shares
|
208,219 |
|
|
| Direct
Value |
$2,880,716 |
|
|
|
Indirect Value
|
$4,176,873 |
|
|
| Total
Shares |
351,824 |
|
|
| Total
Value |
$7,057,589 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 21.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-02-14 |
143,605 |
2024-02-14 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-08-29 |
4 |
AS |
$18.04 |
$315,700 |
I/I |
(17,500) |
218,390 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-09-04 |
4 |
AS |
$19.05 |
$333,375 |
I/I |
(17,500) |
200,890 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-10-01 |
4 |
AS |
$21.72 |
$380,100 |
I/I |
(17,500) |
183,390 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-11-15 |
4/A |
AS |
$18.07 |
$316,157 |
I/I |
(17,500) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-11-15 |
4/A |
OE |
$5.28 |
$64,601 |
I/I |
12,235 |
195,625 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-11-15 |
4 |
AS |
$18.07 |
$316,157 |
I/I |
(17,500) |
165,890 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-12-03 |
4/A |
OE |
$5.28 |
$92,400 |
I/I |
17,500 |
195,625 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-12-03 |
4 |
AS |
$18.43 |
$322,834 |
I/I |
(17,500) |
148,390 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-12-03 |
4/A |
AS |
$18.43 |
$322,834 |
I/I |
(17,500) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-02 |
4/A |
AS |
$19.43 |
$112,937 |
I/I |
(5,775) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-02 |
4/A |
OE |
$5.28 |
$30,492 |
I/I |
5,775 |
183,900 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-02 |
4 |
AS |
$19.43 |
$112,937 |
I/I |
(5,775) |
142,615 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-03 |
4 |
OE |
$5.28 |
$30,492 |
D/D |
5,775 |
8,552 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-03 |
4/A |
AS |
$18.90 |
$109,148 |
I/I |
(5,775) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-03 |
4/A |
OE |
$5.28 |
$30,492 |
I/I |
5,775 |
183,900 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-03 |
4 |
AS |
$18.90 |
$52,485 |
D/D |
(2,777) |
2,777 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-04 |
4/A |
AS |
$19.30 |
$118,084 |
I/I |
(5,950) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-04 |
4/A |
OE |
$5.28 |
$31,416 |
I/I |
5,950 |
184,075 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-04 |
4 |
AS |
$19.30 |
$118,084 |
D/D |
(5,950) |
2,777 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-04 |
4 |
OE |
$5.28 |
$31,416 |
D/D |
5,950 |
8,727 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-01 |
4 |
AS |
$18.64 |
$107,646 |
D/D |
(5,775) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-01 |
4 |
OE |
$5.28 |
$30,492 |
D/D |
5,775 |
5,775 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-04 |
4 |
OE |
$5.28 |
$20,428 |
D/D |
3,869 |
3,869 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-04 |
4 |
AS |
$18.49 |
$72,015 |
D/D |
(3,869) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-05 |
4 |
AS |
$18.83 |
$147,928 |
D/D |
(7,856) |
0 |
0 |
- |
|
108 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
